+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Nerve Repair And Regeneration Market Size, Share & Trends Analysis Report By Surgery (Nerve Grafting, Neurorrhaphy), By Product (Biomaterials Neurostimulation & Neuromodulation Device), By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 110 Pages
  • May 2023
  • Region: Global
  • Grand View Research
  • ID: 4538871
Description Jump to:
The global nerve repair and regeneration market size is expected to reach USD 20.5 billion by 2030. It is expected to expand at a CAGR of 12.16% from 2023 to 2030. Demand for neurological disorder therapies owing to the increasing incidence and rising awareness regarding the same will drive the market. Moreover, government funding and reimbursement policies and uninterrupted technological advances are projected to boost market growth.

In January 2016, the EU Horizon 2020 program funded a research project ‘Autostem’, launched by the NUI Galway’s Regenerative Medicine Institute (REMEDI), costing about USD 6.73 million. This project was to develop a robotic stem cell production factory, having an edge over the old traditional techniques. This technique offers prospects for new therapies for a range of diseases, such as cancers, diabetes, and arthritis. Increased R&D and investments by key companies in emerging countries are also driving the market. In July 2018, Stem Cells Australia (SCA) received USD 3 million for stem cell research from the Medical Research Future Fund (MRFF).

In addition, government and private funded organizations are conducting clinical trials to develop a safe and effective therapy for different neurological disorders, such as Stem Cells in Umbilical Blood Infusion for Cerebral Palsy (Phase II) and the usage of Polyethylene glycol (PEG) drug (Phase I) to promote axonal fusion technique to repair peripheral nerve injuries in humans.

Furthermore, in October 2017, Stryker Corporation acquired VEXIM, a France-based medical device company. VEXIM's portfolio is complementary to Stryker's Interventional Spine (IVS) portfolio. With this acquisition, Stryker will strengthen its distribution channels in Eastern Europe, the Middle East, Asia, and Latin America. In January 2018, Boston Scientific Corporation received U. S. FDA approval for the first and only Spectra WaveWriter spinal cord stimulator system. This system is used for paresthesia-based therapy.

Nerve Repair And Regeneration Market Report Highlights

  • In 2022, the neuromodulation and neurostimulation devices product segment led the market due to the increased cases of Central Nervous System (CNS) disorders and awareness regarding mental disorders and available treatments
  • The biomaterials product segment is anticipated to expand at the fastest CAGR during the forecast period due to technological advancements and the development of biodegradable polymers that can help enhance spinal stabilization and healing of fractures and reduce hospitalization
  • North America led the market in 2022 owing to technological advancements and the advent of new devices. Government initiatives and funding and increased cases of injured CNS, such as injuries to the spinal cord and brain, were some of the major reasons responsible for the regional market growth
  • Asia Pacific is expected to be the fastest-growing regional market during the forecast period. The growing geriatric population, technological advancements, and many unmet medical needs are some of the factors driving the regional market
  • The combination of therapies including a cocktail of peptides, nerve stimulation techniques, injecting the brain with stem cells, and other techniques that were successful in bringing patients out of coma were to be used
  • Existing medical devices were combined with regenerative biological medicines with the objective to achieve such a complex initiative


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.4 Information or Data Analysis
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.2 Volume Price Analysis (model 2)
1.7 List of Secondary Sources
1.8 List of Abbreviations
1.9 Objectives
1.9.1 Objective - 1
1.9.2 Objective - 2
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Landscape Outlook
Chapter 3 Market Variables, Trends & Scope
3.1 Market Lineage outlook
3.1.1 Parent Market Outlook
3.2 Market Segmentation
3.3 Penetration & Growth Prospect Mapping
3.3.1 Penetration & Growth Prospect Mapping
3.4 Regulatory Framework & Reimbursement Scenario
3.5 Market Dynamics
3.5.1 Market Driver Analysis
3.5.1.1 Increasing government fundings and reimbursements
3.5.1.2 Increasing incidences of the neurological disorders
3.5.1.3 Rising medical tourism
3.5.2 Market Restraint Analysis
3.5.2.1 Lack of awareness in the patients for treatment of nerve repair and regeneration
3.5.2.2 High cost of the treatment and unavailability of trained medical personnel
3.6 Business Environment Analysis Tools
3.6.1 Porter’s Five Forces Analysis
3.6.1.1 Bargaining power of buyers: Moderate
3.6.1.2 Bargaining power of suppliers: Low
3.6.1.3 Competitive rivalry: High
3.6.1.4 Threat of new entrants: Moderate
3.6.1.5 Threat of substitutes: Moderate
3.6.2 PESTEL Analysis
3.6.2.1 Political & legal landscape
3.6.2.2 Economic landscape
3.6.2.3 Social landscape
3.6.2.4 Technological landscape
3.6.2.5 Environmental landscape
3.7 Major Deals & Strategic Alliances Analysis
3.7.1 Mergers & Acquisitions
3.7.2 Licensing & Partnership
Chapter 4 Nerve Repair And Regeneration Market: Product Analysis
4.1 Nerve Repair And Regeneration Product Market Share Analysis, 2022
4.2 Nerve Repair And Regeneration Product Market: Segment Dashboard:
4.3 Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Product Segment
4.3.1 Biosimilars
4.3.1.1 Biosimilars market, 2018 - 2030 (USD Million)
4.3.2 Neurostimulation & Neuromodulation Devices
4.3.2.1 Spinal cord stimulation devices market, 2018 - 2030 (USD Million)
4.3.2.2. Deep brain stimulation devices market, 2018 - 2030 (USD Million)
4.3.2.3 Sacral nerve stimulation devices market, 2018 - 2030 (USD Million)
4.3.2.4 Vagus nerve stimulation devices market, 2018 - 2030 (USD Million)
4.3.2.5 Gastric electric stimulation devices market, 2018 - 2030 (USD Million)
Chapter 5 Nerve Repair And Regeneration Market: Surgery Analysis
5.1 Nerve Repair And Regeneration Surgery Market Share Analysis, 2022
5.2 Nerve Repair And Regeneration Surgery Market: Segment Dashboard
5.3 Market Size & Forecasts And Trend Analyses, 2018 - 2030 For The Surgery
5.3.1 Direct Nerve Repair/Neurorrhaphy
5.3.1.1 Direct nerve repair/Neurorrhaphy market, 2018 - 2030 (USD Million)
5.3.2 Nerve Grafting
5.3.2.1 Nerve grafting market, 2018 - 2030 (USD Million)
5.3.3 Stem Cell Therapy
5.3.3.1 Stem cell therapy market, 2018 - 2030 (USD Million)
5.3.4 Neurostimulation & Neuromodulation Surgeries
5.3.4.1 Neurostimulation & neuromodulation surgeries market, 2018 - 2030 (USD Million)
Chapter 6 Nerve Repair And Regeneration Market: Regional Analysis
6.1. Regional market share analysis, 2022 & 2030
6.2. Regional Marketplace: Key Takeaways
6.3. North America
6.3.1. SWOT Analysis
6.3.2. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
6.3.3. U.S.
6.3.3.1. Country Dynamics
6.3.3.2. Country Variables
6.3.3.3. Competitive Landscape
6.3.3.4. Regulatory/Reimbursement Framework
6.3.3.5. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
6.3.4. Canada
6.3.4.1. Country Dynamics
6.3.4.2. Country Variables
6.3.4.3. Competitive Landscape
6.3.4.4. Regulatory/Reimbursement Framework
6.3.4.5. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
6.4. Europe
6.4.1. SWOT Analysis
6.4.2. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
6.4.3. UK
6.4.3.1. Country Dynamics
6.4.3.2. Country Variables
6.4.3.3. Competitive Landscape
6.4.3.4. Regulatory/Reimbursement Framework
6.4.3.5. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
6.4.4. Germany
6.4.4.1. Country Dynamics
6.4.4.2. Country Variables
6.4.4.3. Competitive Landscape
6.4.4.4. Regulatory/Reimbursement Framework
6.4.4.5. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
6.4.5. France
6.4.5.1. Country Dynamics
6.4.5.2. Country Variables
6.4.5.3. Competitive Landscape
6.4.5.4. Regulatory/Reimbursement Framework
6.4.5.5. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
6.4.6. Italy
6.4.6.1. Country Dynamics
6.4.6.2. Country Variables
6.4.6.3. Competitive Landscape
6.4.6.4. Regulatory/Reimbursement Framework
6.4.6.5. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
6.4.7. Spain
6.4.7.1. Country Dynamics
6.4.7.2. Country Variables
6.4.7.3. Competitive Landscape
6.4.7.4. Regulatory/Reimbursement Framework
6.4.7.5. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
6.4.8. Denmark
6.4.8.1. Country Dynamics
6.4.8.2. Country Variables
6.4.8.3. Competitive Landscape
6.4.8.4. Regulatory/Reimbursement Framework
6.4.8.5. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
6.4.9. Sweden
6.4.9.1. Country Dynamics
6.4.9.2. Country Variables
6.4.9.3. Competitive Landscape
6.4.9.4. Regulatory/Reimbursement Framework
6.4.9.5. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
6.4.10. Norway
6.4.10.1. Country Dynamics
6.4.10.2. Country Variables
6.4.10.3. Competitive Landscape
6.4.10.4. Regulatory/Reimbursement Framework
6.4.10.5. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
6.5. Asia Pacific
6.5.1. SWOT Analysis
6.5.2. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
6.5.3. Japan
6.5.3.1. Country Dynamics
6.5.3.2. Country Variables
6.5.3.3. Competitive Landscape
6.5.3.4. Regulatory/Reimbursement Framework
6.5.3.5. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
6.5.4. China
6.5.4.1. Country Dynamics
6.5.4.2. Country Variables
6.5.4.3. Competitive Landscape
6.5.4.4. Regulatory/Reimbursement Framework
6.5.4.5. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
6.5.5. India
6.5.5.1. Country Dynamics
6.5.5.2. Country Variables
6.5.5.3. Competitive Landscape
6.5.5.4. Regulatory/Reimbursement Framework
6.5.5.5. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
6.5.6. Australia
6.5.6.1. Country Dynamics
6.5.6.2. Country Variables
6.5.6.3. Competitive Landscape
6.5.6.4. Regulatory/Reimbursement Framework
6.5.6.5. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
6.5.7. Thailand
6.5.7.1. Country Dynamics
6.5.7.2. Country Variables
6.5.7.3. Competitive Landscape
6.5.7.4. Regulatory/Reimbursement Framework
6.5.7.5. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
6.5.8. South Korea
6.5.8.1. Country Dynamics
6.5.8.2. Country Variables
6.5.8.3. Competitive Landscape
6.5.8.4. Regulatory/Reimbursement Framework
6.5.8.5. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
6.6. Latin America
6.6.1. SWOT Analysis
6.6.2. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
6.6.3. Brazil
6.6.3.1. Country Dynamics
6.6.3.2. Country Variables
6.6.3.3. Competitive Landscape
6.6.3.4. Regulatory/Reimbursement Framework
6.6.3.5. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
6.6.4. Mexico
6.6.4.1. Country Dynamics
6.6.4.2. Country Variables
6.6.4.3. Competitive Landscape
6.6.4.4. Regulatory/Reimbursement Framework
6.6.4.5. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
6.6.5. Argentina
6.6.5.1. Country Dynamics
6.6.5.2. Country Variables
6.6.5.3. Competitive Landscape
6.6.5.4. Regulatory/Reimbursement Framework
6.6.5.5. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
6.7. MEA
6.7.1. SWOT Analysis
6.7.2. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
6.7.3. South Africa
6.7.3.1. Country Dynamics
6.7.3.2. Country Variables
6.7.3.3. Competitive Landscape
6.7.3.4. Regulatory/Reimbursement Framework
6.7.3.5. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
6.7.4. Saudi Arabia
6.7.4.1. Country Dynamics
6.7.4.2. Country Variables
6.7.4.3. Competitive Landscape
6.7.4.4. Regulatory/Reimbursement Framework
6.7.4.5. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
6.7.5. UAE
6.7.5.1. Country Dynamics
6.7.5.2. Country Variables
6.7.5.3. Competitive Landscape
6.7.5.4. Regulatory/Reimbursement Framework
6.7.5.5. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
6.7.6. Kuwait
6.7.6.1. Country Dynamics
6.7.6.2. Country Variables
6.7.6.3. Competitive Landscape
6.7.6.4. Regulatory/Reimbursement Framework
6.7.6.5. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
Chapter 7 Competitive Analysis
7.1 Recent Developments & Impact Analysis, By Key Market Participants
7.2 Strategic Framework/ Competition Categorization (Key Innovators, Market Leaders, Emerging Players
7.3 Vendor Landscape
7.4 Public Companies
7.4.1 Company Market Position Analysis (Revenue, Geographic Presence, Product Portfolio, Strategic Initiatives, Employee Strength)
7.5 Private Companies
7.5.1 Company Market Position Analysis (Geographic Presence, Product Portfolio, Key Alliance, Industry Experience)
7.6 Company Profiles
7.6.1 CYBERONICS, INC
7.6.1.1 Company overview
7.6.1.2 Financial performance
7.6.1.3 Product benchmarking
7.6.1.4 Strategic initiatives
7.6.1.5 SWOT Analysis
7.6.2 MEDTRONIC
7.6.2.1 Company overview
7.6.2.2 Financial performance
7.6.2.3 Product benchmarking
7.6.2.4 Strategic initiatives
7.6.2.5 SWOT Analysis
7.6.3 STRYKER
7.6.3.1 Company overview
7.6.3.2 Financial performance
7.6.3.3 Product benchmarking
7.6.3.4 Strategic initiatives
7.6.3.5 SWOT Analysis
7.6.4 AXOGEN CORPORATION
7.6.4.1 Company overview
7.6.4.2 Financial performance
7.6.4.3 Product benchmarking
7.6.4.4 Strategic initiatives
7.6.4.5 SWOT Analysis
7.6.5 ST. JUDE MEDICAL
7.6.5.1 Company overview
7.6.5.2 Financial performance
7.6.5.3 Product benchmarking
7.6.5.4 Strategic initiatives
7.6.5.5 SWOT Analysis
7.6.6 BAXTER
7.6.6.1 Company overview
7.6.6.2 Financial performance
7.6.6.3 Product benchmarking
7.6.6.4 Strategic initiatives
7.6.6.5 SWOT Analysis
7.6.7 BOSTON SCIENTIFIC CORPORATION
7.6.7.1 Company overview
7.6.7.2 Financial performance
7.6.7.3 Product benchmarking
7.6.7.4 Strategic initiatives
7.6.7.5 SWOT Analysis
7.6.8 POLYGANICS
7.6.8.1 Company overview
7.6.8.2 Financial performance
7.6.8.3 Product benchmarking
7.6.8.4 Strategic initiatives
7.6.9 INTEGRA LIFESCIENCES
7.6.9.1 Company overview
7.6.9.2 Financial performance
7.6.9.3 Product benchmarking
7.6.9.4 Strategic initiatives
7.6.9.5 SWOT Analysis
List of Tables
Table 1 List of secondary sources
TABLE 2 List of Abbreviation
TABLE 3 List of players in North America
TABLE 4 List of players in Europe
TABLE 5 List of players in Asia Pacific
TABLE 6 List of players in Latin America
TABLE 7 List of players in MEA
TABLE 8 North America nerve repair and regeneration market, by country, 2018 - 2030 (USD Million)
TABLE 9 North America nerve repair and regeneration market, by product, 2018 - 2030 (USD Million)
TABLE 10 North America nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 11 North America nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
TABLE 12 U.S. nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
TABLE 13 U.S. nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 14 U.S. nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
TABLE 15 Canada. nerve repair and regeneration market, by product, 2018 - 2030 (USD Million)
TABLE 16 Canada. nerve repair and regeneration market, by neurostimulation and neuromodulation devices 2018 - 2030 (USD Million)
TABLE 17 Canada nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
TABLE 18 Europe nerve repair and regeneration market, by country, 2018 - 2030 (USD Million)
TABLE 19 Europe nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
TABLE 20 Europe nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 21 Europe nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
TABLE 22 U.K. nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
TABLE 23 U.K. nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 24 U.K. nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
TABLE 25 Germany nerve repair and regeneration market, by product, 2018 - 2030 (USD Million)
TABLE 26 Germany nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 27 Germany nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
TABLE 28 France nerve repair and regeneration market, by product, 2018 - 2030 (USD Million)
TABLE 29 France nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 30 France nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
TABLE 31 Italy nerve repair and regeneration market, by product, 2018 - 2030 (USD Million)
TABLE 32 Italy nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 33 Italy nerve repair and regeneration Market, by surgery, 2018 - 2030 (USD Million)
TABLE 34 Spain nerve repair and regeneration market, by product, 2018 - 2030 (USD Million)
TABLE 35 Spain nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 36 Spain nerve repair and regeneration Market, by surgery, 2018 - 2030 (USD Million)
TABLE 37 Denmark nerve repair and regeneration market, by product, 2018 - 2030 (USD Million)
TABLE 38 Denmark nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 39 Denmark nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
TABLE 40 Sweden nerve repair and regeneration market, by product, 2018 - 2030 (USD Million)
TABLE 41 Sweden nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 42 Sweden nerve repair and regeneration Market, by surgery, 2018 - 2030 (USD Million)
TABLE 34 Norway nerve repair and regeneration market, by product, 2018 - 2030 (USD Million)
TABLE 43 Norway nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 44 Norway nerve repair and regeneration Market, by surgery, 2018 - 2030 (USD Million)
TABLE 45 Asia Pacific nerve repair and regeneration market, by country, 2018 - 2030 (USD Million)
TABLE 46 Asia Pacific nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
TABLE 47 Asia Pacific nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 48 Asia Pacific nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
TABLE 49 Japan nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
TABLE 50 Japan nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 51 Japan nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
TABLE 52 China nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
TABLE 53 China nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 54 China nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
TABLE 55 India nerve repair and regeneration market, by product, 2018 - 2030 (USD Million)
TABLE 56 India nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 57 India nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
TABLE 58 Australia nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
TABLE 59 Australia nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 60 Australia nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
TABLE 61 South Korea nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
TABLE 62 South Korea nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 63 South Korea nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
TABLE 64 Thailand nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
TABLE 65 Thailand nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 66 Thailand nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
TABLE 67 Latin America nerve repair and regeneration market, by country, 2018 - 2030 (USD Million)
TABLE 68 Latin America nerve repair and regeneration market, by product, 2018 - 2030 (USD Million)
TABLE 69 Latin America nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 70 Latin America nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
TABLE 71 Brazil nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
TABLE 72 Brazil nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 73 Brazil. nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
TABLE 74 Mexico nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
TABLE 75 Mexico nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 76 Mexico nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
TABLE 77 Argentina nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
TABLE 78 Argentina nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 79 Argentina nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
TABLE 80 MEA nerve repair and regeneration market, by country, 2018 - 2030 (USD Million)
TABLE 81 MEA nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
TABLE 82 MEA nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 83 MEA nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
TABLE 84 South Africa nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
TABLE 85 South Africa nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 86 South Africa nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
TABLE 87 UAE nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
TABLE 88 UAE nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 89 UAE nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
TABLE 90 Saudi Arabia nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
TABLE 91 Saudi Arabia nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 92 Saudi Arabia Nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
TABLE 93 Kuwait nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
TABLE 94 Kuwait nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
TABLE 95 Kuwait Nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market formulation & validation
FIG. 8 Market outlook
FIG. 9 Nerve repair and regeneration market segmentation
FIG. 10 Penetration & growth prospect mapping
FIG. 11 Market trends & outlook
FIG. 12 Market driver relevance analysis (Current & future impact)
FIG. 13 Market restraint relevance analysis (Current & future impact)
FIG. 14 PORTER'S five forces analysis
FIG. 15 PESTLE analysis
FIG. 16 Nerve repair and regeneration product market share analysis, 2022
FIG. 17 Nerve repair and regeneration product market: Segment dashboard
FIG. 18 Biosimilars nerve repair and regeneration market, 2018 - 2030 (USD Million)
FIG. 19 Neurostimulation and neuromodulation devices nerve repair and regeneration market, 2018 - 2030 (USD Million)
FIG. 20 Nerve repair and regeneration surgery market share analysis, 2022
FIG. 21 Nerve repair and regeneration surgery market: Segment dashboard
FIG. 22 Direct nerve repair/Neurorrhaphy market, 2018 - 2030 (USD Million)
FIG. 23 Nerve grafting market, 2018 - 2030 (USD Million)
FIG. 24 Stem cell therapy market, 2018 - 2030 (USD Million)
FIG. 25 Neurostimulation and neuromodulation surgeries market, 2018 - 2030 (USD Million)
FIG. 26 Nerve repair and regeneration regional market share analysis, 2022
FIG. 27 Nerve repair and regeneration regional market: Segment dashboard
FIG. 28 Nerve repair and regeneration market place: Key takeaways
FIG. 29 North America Nerve repair and regeneration market, 2018 - 2030 (USD Million)
FIG. 30 U.S. Nerve repair and regeneration market, 2018 - 2030 (USD Million)
FIG. 31 Canada Nerve repair and regeneration market, 2018 - 2030 (USD Million)
FIG. 32 Europe Nerve repair and regeneration market, 2018 - 2030 (USD Million)
FIG. 33 U.K. Nerve repair and regeneration market, 2018 - 2030 (USD Million)
FIG. 34 Germany Nerve repair and regeneration market, 2018 - 2030 (USD Million)
FIG. 35 France Nerve repair and regeneration market, 2018 - 2030 (USD Million)
FIG. 36 Italy Nerve repair and regeneration market, 2018 - 2030 (USD Million)
FIG. 37 Spain Nerve repair and regeneration market, 2018 - 2030 (USD Million)
FIG. 38 Denmark Nerve repair and regeneration market, 2018 - 2030 (USD Million)
FIG. 39 Sweden Nerve repair and regeneration market, 2018 - 2030 (USD Million)
FIG. 40 Norway Nerve repair and regeneration market, 2018 - 2030 (USD Million)
FIG. 41 Asia Pacific Nerve repair and regeneration market, 2018 - 2030 (USD Million)
FIG. 42 Japan Nerve repair and regeneration market, 2018 - 2030 (USD Million)
FIG. 43 China Nerve repair and regeneration market, 2018 - 2030 (USD Million)
FIG. 44 India Nerve repair and regeneration market, 2018 - 2030 (USD Million)
FIG. 45 Australia Nerve repair and regeneration market, 2018 - 2030 (USD Million)
FIG. 46 South Korea Nerve repair and regeneration market, 2018 - 2030 (USD Million)
FIG. 47 Thailand Nerve repair and regeneration market, 2018 - 2030 (USD Million)
FIG. 48 Latin America Nerve repair and regeneration market, 2018 - 2030 (USD Million)
FIG. 49 Brazil Nerve repair and regeneration market, 2018 - 2030 (USD Million)
FIG. 50 Mexico Nerve repair and regeneration market, 2018 - 2030 (USD Million)
FIG. 51 Argentina Nerve repair and regeneration market, 2018 - 2030 (USD Million)
FIG. 52 MEA Nerve repair and regeneration market, 2018 - 2030 (USD Million)
FIG. 53 South Africa Nerve repair and regeneration market, 2018 - 2030 (USD Million)
FIG. 54 UAE Nerve repair and regeneration market, 2018 - 2030 (USD Million)
FIG. 55 Saudi Arabia Nerve repair and regeneration market, 2018 - 2030 (USD Million)
FIG. 56 Kuwait Nerve repair and regeneration market, 2018 - 2030 (USD Million)
FIG. 57 Strategy framework
FIG. 58 Competition categorization
FIG. 59 Company market position analysis (revenue, geographic presence, product portfolio, strategic initiatives, employee strength)

Companies Mentioned

  • CYBERONICS, INC
  • MEDTRONIC
  • STRYKER
  • AXOGEN CORPORATION
  • ST. JUDE MEDICAL
  • BAXTER
  • BOSTON SCIENTIFIC CORPORATION
  • POLYGANICS
  • INTEGRA LIFESCIENCES

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages110
PublishedMay 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 8.1 Billion
Forecasted Market Value ( USD ) by 2030 $ 20.5 Billion
Compound Annual Growth Rate12.1%
Regions CoveredGlobal
No. of Companies Mentioned9

Related Topics

Related Reports

Global Nerve Repair & Regeneration Market by Product (Biomaterials, Neurostimulation & Neuromodulation Devices), Application (Direct Nerve Repair/Neurorrhaphy, Nerve Grafting, Neurostimulation & Neuromodulation Surgeries), End-User - Forecast 2024-2030 - Product Image

Global Nerve Repair & Regeneration Market by Product (Biomaterials, Neurostimulation & Neuromodulation Devices), Application (Direct Nerve Repair/Neurorrhaphy, Nerve Grafting, Neurostimulation & Neuromodulation Surgeries), End-User - Forecast 2024-2030

  • Report
  • 194 Pages
  • Global
From
Nerve Repair and Regeneration Devices - Global Strategic Business Report - Product Image

Nerve Repair and Regeneration Devices - Global Strategic Business Report

  • Report
  • 510 Pages
  • Global
From
Global Nerve Repair & Regeneration Market (2023-2028) Competitive Analysis, Impact of Covid-19, Impact of Economic Slowdown & Impending Recession, Ansoff Analysis - Product Image

Global Nerve Repair & Regeneration Market (2023-2028) Competitive Analysis, Impact of Covid-19, Impact of Economic Slowdown & Impending Recession, Ansoff Analysis

  • Report
  • 215 Pages
  • Global
From
Global Nerve Repair and Regeneration Market Report by Surgery, Product, End User, and Region 2023-2028 - Product Image

Global Nerve Repair and Regeneration Market Report by Surgery, Product, End User, and Region 2023-2028

  • Report
  • 148 Pages
  • Global
From
Nerve Repair and Regenerative Global Market Report 2024 - Product Image

Nerve Repair and Regenerative Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From

About the Nerve Repair Market

The Nerve Repair market within the context of Genomics is focused on the development of treatments and therapies that can help to repair damaged nerves. This includes the use of gene therapy, stem cell therapy, and other regenerative medicine approaches. Genomics has enabled researchers to better understand the genetic basis of nerve damage and to develop treatments that can target specific genetic pathways. In addition, genomics has enabled the development of personalized treatments that can be tailored to the individual patient. Companies in the Nerve Repair market include AxoGen, Inc., BioTime, Inc., BrainStorm Cell Therapeutics, Inc., and Neuralstem, Inc. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.